Gastroenterology

The MD Magazine editors rounded up the 10 best stories from January—did you read them all?

The main cause of C. difficile is antibiotics, not hospital conditions.

Phase 2 study shows promising results for potential C. difficile vaccine candidate.

The key to fighting autism might be lurking in the gut.

Two decades later the ACG updates new guidelines for H. pylori.

There's a potential link between changes in the gut and type 1 diabetes.

The FDA today approved constipation remedy plecanatide.

New trial tests efficacy of CanChew Plus cannabidiol gum to treat IBS.

HOST-G904 showed positive results for treating severe bowel conditions.

C. diff infections appear to lurk in long-term acute care facilities.

C. diff guideline highlights the need for international agreement.

CDC official is hopeful they can beat C diff infection.

Patients using fidaxomicin for C diff infection experienced no recurrences..

Researchers, for the first time, used the lyophilized non-frozen oral capsule RBX7455 to treat a patient with recurrent Clostridium difficile (C. difficile) infection.

Heartburn drugs like Prilosec and Nexium might alleviate acid reflux, but could raise the risk of severe stomach infections.

While the culprit for the stomach pain and discomfort in autistic children was unknown for quite some time, new research suggests it could be caused by an “increased reaction to stress”.

The MD Magazine editors rounded up the 10 best stories from December—did you read them all?

While effective for Clostridium difficile (C. difficile) infection in irritable bowel syndrome (IBS) patients, fecal microbiota transplants did not relieve the IBS itself.

Many off label therapeutic options currently exist for treating Clostridium difficile (C. difficile) infection, but combinations of these choices can develop into viable, approved treatments, according to a recently published product review.

Traces of Clostridium difficile bacteria are occasionally found in the final products of manure compost and can even transfer C. difficile into the food chain.

According to new research, fecal transplantations were just as effective as the standard Clostridium difficile (C. difficile) treatment, oral vancomycin taper, in patients with recurrent C. difficile infections.

The antibiotic oral vancomycin can potentially prevent C. difficile infections in patients undergoing stem cell transplants, new research finds.

In a letter, the Textile Rental Services Association strongly responded to the article. David F. Goldsmith, MSPH, PhD, wrote that the story on hospital laundry facilities could “misleadingly create false alarms.”

Patients suffering from irritable bowel syndrome with constipation (IBS-C) may benefit from a new drug, plecanatide, making its way through the approval pipeline.

Between 2012 and 2014, 19 Pomona Valley patients died from C. difficile infection. One environmental services employee quoted in the LA Times said that she had not received any training on infection control in her 12 years of employment there.

Age-related macular degeneration, the leading cause of blindness in the developed world, has long been linked to diet and obesity. Recently, we came closer to understanding just exactly why that is.

A team was able to demonstrate that spinal cord injury causes the relocation of some of the gut’s bacteria from sterile tissues to other locations throughout the body, and it appeared that these changes were linked to the activation of the immune system cells in the gut.

At AHA 2016, Poushali Mukherjea, PhD, Bristol-Myers Squibb, discusses 12 abstracts on new real-world data and subanalyses from the pivotal trial ARISTOTLE.

A Polish research team concluded that there are two mortality models for patients with pneumonia being treated for Clostridium difficile infection. and recommended the exclusion of one antibiotic from pneumonia treatment in hospitals.

The MD Magazine editors rounded up the 10 best stories from November – did you read them all?